Precede Biosciences Presents New Data at ASCO 2024 Demonstrating Accurate HER2 Status Detection Across Multiple Cancers and the Ability to Quantify ER Pathway Activation in Breast Cancer from a Simple Blood Test
GlobeNewswire
· HER2 status was accurately assessed in 172 patients with advanced breast, gastroesophageal, and ovarian cancers
· ER..